Short communication · 21 Jun 2021
Research articlePublished 11 May 2016
Hepato-renal protective effects of gallic acid and p-coumaric acid in nicotinamide/streptozotocin-induced diabetic rats
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The goal of diabetes treatment is primarily to save life and alleviate symptoms and secondary to prevent long-term diabetic complications resulting from hyperglycemia. Thus, our present investigation was designed to evaluate the hepato-renal protective effects of gallic acid and p-coumaric acid in nicotinamide/streptozotocin (NA/STZ)-induced diabetic rats. Experimental type 2 diabetes was induced by a single intraperitoneal (i.p.) injection of STZ (65 mg/kg b.wt.), after 15 min of i.p. injection of NA (120 mg/kg b.wt.). Gallic acid and p-coumaric acid were orally administered to diabetic rats at a dose of 20, 40 mg/kg b.wt./day, respectively, for 6 weeks. Body weight, serum glucose, protein profile, liver function enzymes and kidney function indicators was assayed. Treatment with either gallic acid or p-coumaric acid significantly ameliorated the elevated levels of glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea and uric acid. Both compounds were also found to restore total protein, albumin, and globulin as well as body weight of diabetic rats to near normal values. It can conclude that both gallic acid and p-coumaric acid have potent hypoglycemic and hepato-renal protective effects in diabetic rats. Therefore, our results suggest promising hypoglycemic agents that can attenuate the progression of diabetic hepatopathy and nephropathy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Bioassays.
Short communication · 21 Jun 2021
Pharmacology and Chromatography and HPLC Congress 2018: Role of biobanking in discovering pharmacologic biomarker targets for the practice of precision medicine - Richard L Summers - University of Mississippi Medical Center
Short communication · 21 Jun 2021
Pharmacology and Chromatography and HPLC Congress 2018: Glycyl - lutamine: A new hope in the treatment of depression? - Sinan Cavun - Uludag University
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Bioassays
- SubjectDiabetes & Endocrinology
- SubjectGastroenterology & Hepatology
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Adel Abdel Moneim”
- BylineArticles whose byline prints “Sanaa M. Abd El-Twab”
- BylineArticles whose byline prints “Mohamed B. Ashour”
- BylineArticles whose byline prints “Ahmed I. Yousef”